Protection by vascular prostaglandin E2 signaling in hypoxic-ischemic encephalopathy

Experimental Neurology

Volumn 255, Issue , 2014, Pages 30-37

  Taniguchi, Hidetoshi ^a,b   Anacker, Christoph ^a,c   Wang, Qian ^a   Andreasson, Katrin ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

Author keywords

Cerebral protection; Conditional knockout; Endothelium; Hypoxic ischemic encephalopathy

Indexed keywords

CRE RECOMBINASE; ENDOTHELIAL EP4 RECEPTOR; G PROTEIN COUPLED RECEPTOR; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN PERFUSION; BRAIN PROTECTION; CELL SPECIFICITY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IN VIVO STUDY; KNOCKOUT MOUSE; LEFT HEMISPHERE; MALE; MEASUREMENT; MOUSE; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RIGHT HEMISPHERE; RODENT; SIGNAL TRANSDUCTION; VASCULAR DISEASE;

CEREBRAL PROTECTION; CONDITIONAL KNOCKOUT; ENDOTHELIUM; HYPOXIC-ISCHEMIC ENCEPHALOPATHY; PGE(2) EP4 RECEPTOR;

ANIMALS; CEREBROVASCULAR CIRCULATION; DINOPROSTONE; DISEASE MODELS, ANIMAL; FEMALE; HYPOXIA-ISCHEMIA, BRAIN; MALE; MICE, KNOCKOUT; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE; SIGNAL TRANSDUCTION;

EID: 84895758446     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2014.02.012     Document Type: Article

References (43)

1. 2. Am. J. Physiol. 1999, 277:H924-H930.
2. Baburamani A.A., Ek C.J., Walker D.W., Castillo-Melendez M. Vulnerability of the developing brain to hypoxic-ischemic damage: contribution of the cerebral vasculature to injury and repair?. Front. Physiol. 2012, 3:424.
3. Briers J.D. Laser Doppler, Speckle and related techniques for blood perfusion mapping and imaging. Physiol. Meas. 2001, 22:R35-R66.
4. Clancy B., Darlington R.B., Finlay B.L. Translating developmental time across mammalian species. Neuroscience 2001, 105:7-17.
5. Dalkara T., Morikawa E., Panahian N., Moskowitz M.A. Blood flow-dependent functional recovery in a rat model of focal cerebral ischemia. Am. J. Physiol. 1994, 267:H678-H683.
6. Dumont I., Hou X., Hardy P., Peri K.G., Beauchamp M., Najarian T., Molotchnikoff S., Varma D.R., Chemtob S. Developmental regulation of endothelial nitric oxide synthase in cerebral vessels of newborn pig by prostaglandin E(2). J. Pharmacol. Exp. Ther. 1999, 291:627-633.
7. Dunn A.K., Bolay H., Moskowitz M.A., Boas D.A. Dynamic imaging of cerebral blood flow using laser speckle. J. Cereb. Blood Flow Metab. 2001, 21:195-201.
8. Gonzalez F.F., Ferriero D.M. Neuroprotection in the newborn infant. Clin. Perinatol. 2009, 36:859-880. (vii).
9. Grow J., Barks J.D. Pathogenesis of hypoxic-ischemic cerebral injury in the term infant: current concepts. Clin. Perinatol. 2002, 29:585-602. (v).
10. 2 receptor subtype 1 targeting. J. Clin. Invest. 2007, 117:2496-2505.
11. Huang Z., Huang P.L., Ma J., Meng W., Ayata C., Fishman M.C., Moskowitz M.A. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-l-arginine. J. Cereb. Blood Flow Metab. 1996, 16:981-987.
12. Johnston M.V., Trescher W.H., Ishida A., Nakajima W. Novel treatments after experimental brain injury. Semin. Neonatol. 2000, 5:75-86.
13. Johnston M.V., Fatemi A., Wilson M.A., Northington F. Treatment advances in neonatal neuroprotection and neurointensive care. Lancet Neurol. 2011, 10:372-382.
14. 2 receptor. Nat. Med. 1999, 5:217-220.
15. 2 EP4 receptor in a mouse model of cerebral ischemia. J. Clin. Invest. 2011, 121:4362-4371.
16. Lin T.N., He Y.Y., Wu G., Khan M., Hsu C.Y. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 1993, 24:117-121.
17. Maruyama T., Asada M., Shiraishi T., Ishida A., Egashira H., Yoshida H., Ohuchida S., Nakai H., Kondo K., Toda M. Design and synthesis of a highly selective EP4-receptor agonist. Part 1: 3,7-dithiaPG derivatives with high selectivity. Bioorg. Med. Chem. Lett. 2001, 11:2029-2031.
18. McLean C., Ferriero D. Mechanisms of hypoxic-ischemic injury in the term infant. Semin. Perinatol. 2004, 28:425-432.
19. Minami M., Shimizu K., Okamoto Y., Folco E., Ilasaca M.L., Feinberg M.W., Aikawa M., Libby P. Prostaglandin E receptor type 4-associated protein interacts directly with NF-kappaB1 and attenuates macrophage activation. J. Biol. Chem. 2008, 283:9692-9703.
20. T2 transgenic mouse: a model for inducible recombination in the endothelium. Dev. Dyn. 2006, 235:3413-3422.
21. Morikawa E., Moskowitz M.A., Huang Z., Yoshida T., Irikura K., Dalkara T. l-Arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rat. Stroke 1994, 25:429-435.
22. Ohshima M., Tsuji M., Taguchi A., Kasahara Y., Ikeda T. Cerebral blood flow during reperfusion predicts later brain damage in a mouse and a rat model of neonatal hypoxic-ischemic encephalopathy. Exp. Neurol. 2012, 233:481-489.
23. Pietrini D., Piastra M., Luca E., Mancino A., Conti G., Cavaliere F., De Luca D. Neuroprotection and hypothermia in infants and children. Curr. Drug Targets 2012, 13:925-935.
24. Renic M., Klaus J.A., Omura T., Kawashima N., Onishi M., Miyata N., Koehler R.C., Harder D.R., Roman R.J. Effect of 20-HETE inhibition on infarct volume and cerebral blood flow after transient middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 2009, 29:629-639.
25. Rice J.E., Vannucci R.C., Brierley J.B. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann. Neurol. 1981, 9:131-141.
26. Saleem S., Li R.C., Wei G., Dore S. Effects of EP1 receptor on cerebral blood flow in the middle cerebral artery occlusion model of stroke in mice. J. Neurosci. Res. 2007, 85:2433-2440.
27. Schneider A., Guan Y., Zhang Y., Magnuson M.A., Pettepher C., Loftin C.D., Langenbach R., Breyer R.M., Breyer M.D. Generation of a conditional allele of the mouse prostaglandin EP4 receptor. Genesis 2004, 40:7-14.
28. 2 E-prostanoid 4 receptor exerts anti-inflammatory effects in brain innate immunity. J. Immunol. 2010, 184:7207-7218.
29. Suzawa T., Miyaura C., Inada M., Maruyama T., Sugimoto Y., Ushikubi F., Ichikawa A., Narumiya S., Suda T. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology 2000, 141:1554-1559.
30. 2 modulation of blood pressure homeostasis: studies in rodent models. Prostaglandins Other Lipid Mediat. 2011, 96:10-13.
31. Takayama K., Sukhova G.K., Chin M.T., Libby P. A novel prostaglandin E receptor 4-associated protein participates in antiinflammatory signaling. Circ. Res. 2006, 98:499-504.
32. Taniguchi H., Andreasson K. The hypoxic-ischemic encephalopathy model of perinatal ischemia. J. Vis. Exp. 2008, 21. (pii: 955). 10.3791/955.
33. Taniguchi H., Mohri I., Okabe-Arahori H., Aritake K., Wada K., Kanekiyo T., Narumiya S., Nakayama M., Ozono K., Urade Y., Taniike M. Prostaglandin D2 protects neonatal mouse brain from hypoxic-ischemic injury. J. Neurosci. 2007, 27:4303-4312.
34. 2 EP receptors in the acute outcome of rodent hypoxic-ischemic encephalopathy. Neurosci. Lett. 2011, 504:185-190.
35. 2 receptor. J. Clin. Invest. 1999, 103:1539-1545.
36. Vannucci S.J., Hagberg H. Hypoxia-ischemia in the immature brain. J. Exp. Biol. 2004, 207:3149-3154.
37. Vannucci R.C., Vannucci S.J. Perinatal hypoxic-ischemic brain damage: evolution of an animal model. Dev. Neurosci. 2005, 27:81-86.
38. Vannucci R.C., Lyons D.T., Vasta F. Regional cerebral blood flow during hypoxia-ischemia in immature rats. Stroke 1988, 19:245-250.
39. Vexler Z.S., Yenari M.A. Does inflammation after stroke affect the developing brain differently than adult brain?. Dev. Neurosci. 2009, 31:378-393.
40. Wainwright M.S., Grundhoefer D., Sharma S., Black S.M. A nitric oxide donor reduces brain injury and enhances recovery of cerebral blood flow after hypoxia-ischemia in the newborn rat. Neurosci. Lett. 2007, 415:124-129.
41. Yepes M., Sandkvist M., Moore E.G., Bugge T.H., Strickland D.K., Lawrence D.A. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J. Clin. Invest. 2003, 112:1533-1540.
42. Zhang F., White J.G., Iadecola C. Nitric oxide donors increase blood flow and reduce brain damage in focal ischemia: evidence that nitric oxide is beneficial in the early stages of cerebral ischemia. J. Cereb. Blood Flow Metab. 1994, 14:217-226.
43. Zhang Y., Guan Y., Schneider A., Brandon S., Breyer R.M., Breyer M.D. Characterization of murine vasopressor and vasodepressor prostaglandin E(2) receptors. Hypertension 2000, 35:1129-1134.